PWR (PWH) H1 2025 earnings summary

Executive summary

• Revenue for H1 FY25 declined 2.1% year-over-year to $62.9 million, but was slightly ahead of guidance, with strong 79% growth in Aerospace & Defence and 5% growth in Motorsports offset by declines in OEM and Aftermarket segments.

• Net profit after tax dropped 58.3% to $4.1 million, with EPS at 4.06 cents, but remained above guidance.

• Major investments in the new Australian Stapylton factory and global capacity upgrades are underway, supported by an AUD 8.8 million Queensland government grant.

• The business remains in a net cash position after significant investments, reflecting strong cash generation and disciplined capital allocation.

• Strategic diversification continues, focusing on Aerospace & Defence, with new product commercialization and technical expertise investments.

Financial highlights

• Revenue: $62.9 million (down 2.1% year-over-year); EBITDA: $11.0 million (down 40.2%); NPAT: $4.1 million (down 58.3%).

• EBITDA margin dropped to 17.5% from 28.7%; EPS fell 58% to 4.06c; ROE declined 10.2ppts to 16.5%.

• Net cash position at December 2024 was $6.0 million, with cash and undrawn facilities totaling $43.5 million.

• Fully franked interim dividend of 2.00 cents per share declared, representing a 49% payout ratio.

• Capital expenditure for the period was $14.2 million, with a full-year forecast of $41.5 million, mainly for factory upgrades and equipment.

Outlook and guidance

• FY25 revenue is expected to be 5%-10% below FY24 due to short-term production disruption from the factory move and timing of Aerospace & Defence deliveries.

• The new Australian Stapylton factory is on track for full completion by November 2025, expected to drive efficiency and capacity for A&D growth.

• Motorsport revenue is expected to see a significant uplift in 2026 with F1 regulation changes and the addition of an 11th team.

• The R&D pipeline is growing, with longer timelines for delivery and increasing visibility of future earnings.

• Full impact of cost control measures, including restructuring and price increases, is expected in future results.